BIOMARIN PHARMACEUTICAL INC (BMRN) Goodwill USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Biomarin Pharmaceutical Inc quarterly Goodwill history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Goodwill for the quarter ending March 31, 2024 was $196 M, unchanged year-over-year.
Goodwill, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $196 M $0 0% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $196 M $0 0% Dec 31, 2023 10-Q 2024-04-26
Q3 2023 $196 M $0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $196 M $0 0% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $196 M $0 0% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $196 M $0 0% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $196 M $0 0% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $196 M $0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $196 M $0 0% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $196 M $0 0% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $196 M $0 0% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $196 M $0 0% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $196 M $0 0% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $196 M -$840 K -0.43% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $196 M -$840 K -0.43% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $196 M -$840 K -0.43% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $196 M -$840 K -0.43% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $197 M $0 0% Dec 31, 2019 10-K 2022-02-25
Q3 2019 $197 M $0 0% Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 $197 M $0 0% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $197 M $0 0% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $197 M $0 0% Dec 31, 2018 10-K 2021-02-26
Q3 2018 $197 M $0 0% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $197 M $0 0% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $197 M $0 0% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $197 M $0 0% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $197 M $0 0% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $197 M $0 0% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $197 M $0 0% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $197 M $0 0% Dec 31, 2016 10-K 2018-02-26
Q3 2016 $197 M -$5.35 M -2.65% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $197 M -$5.35 M -2.65% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $197 M -$5.35 M -2.65% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $197 M +$143 M +263% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $202 M +$148 M +273% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $202 M +$148 M +273% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $202 M +$148 M +273% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $54.3 M $0 0% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $54.3 M $0 0% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 $54.3 M -$717 K -1.3% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $54.3 M -$717 K -1.3% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $54.3 M +$2.72 M +5.27% Dec 31, 2013 10-K 2015-03-02
Q3 2013 $54.3 M +$2.72 M +5.27% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 $55 M +$3.43 M +6.66% Jun 30, 2013 10-Q 2013-07-29
Q1 2013 $55 M +$3.43 M +6.66% Mar 31, 2013 10-Q 2013-04-29
Q4 2012 $51.5 M $0 0% Dec 31, 2012 10-K 2014-02-26
Q3 2012 $51.5 M $0 0% Sep 30, 2012 10-Q 2012-10-29
Q2 2012 $51.5 M -$1.51 M -2.85% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 $51.5 M -$1.51 M -2.85% Mar 31, 2012 10-Q 2012-04-30
Q4 2011 $51.5 M -$1.82 M -3.41% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $51.5 M -$1.82 M -3.41% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 $53.1 M +$12.7 M +31.5% Jun 30, 2011 10-Q 2011-08-01
Q1 2011 $53.1 M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 $53.4 M Dec 31, 2010 10-K 2012-02-22
Q3 2010 $53.4 M Sep 30, 2010 10-Q 2010-10-29
Q2 2010 $40.4 M Jun 30, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.